MEDtalks
EADV 2026: Danish Study Highlights Lasting Benefits of Lebrikizumab in Atopic Dermatitis
/ Ida Marie Nedergaard Thomsen
Obesity and the Risk of MGUS and Myeloma Progression
/ Sæmundur Rögnvaldsson
EHA 2026: Long-Term Outcomes with Zanubrutinib in First-Line CLL
/ Wojciech Jurczak
























